Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users.

Background: The use of long acting injectable (LAA) antiretroviral drugs may be an alternative option for HIV treatment and prevention. Our study focused on patient perspectives to understand which individuals, among people with HIV (PWH) and pre-exposure prophylaxis (PrEP) users, would constitute the preferential target for such treatments in terms of expectations, tolerability, adherence and quality of life.

Methods: The study consisted in one self-administrated questionnaire.

[Not Available].

In June 2020, 32,000 people began HIV Pre-exposure prohylaxis (PrEP) in France. The objective of this work is to propose PrEP for migrants in city medical offices in collaboration with hospitals. This is happening in the Goutte d’Or neighborhood of Paris where one-third of the inhabitants were born abroad [1].

[Fragility and precariousness of people living with HIV].

Fragility and Precariousness of People living with hiv Living with hiv in 2021 means having a Chronic disease that is still not "like the Others". Stigma and discrimination persist. And the prognosis remains uncertain in the Countries of the south where access to care Can be problematic and the emergence of Resistance is a concern.

Addressing sexuality and sexual health with migrants. Practice guidelines.

Sexual health is an integral part of overall health and should be discussed with all people who seek help. The Vaccination and Prevention working group of the French Infectious Diseases Society (SPILF) and the Migrant Commission of the French AIDS Society (SFLS) developed recommendations to address this issue with migrants presenting vulnerability factors. After defining sexual health and target migrants, practical recommendations were issued.